Inhibidores de la neuraminidasa para la profilaxis y tratamiento de la nueva influenza A H1N1
Autor: Dr. Luis Caballero | Publicado:  14/09/2009 | Microbiologia y Parasitologia , Enfermedades Infecciosas , Medicina Preventiva y Salud Publica | |
Inhibidores de la neuraminidasa para la profilaxis y tratamiento de la nueva influenza A H1N1.10

  • Nelson M, Simonsen L, Viboud C, Miller M, Holmes E. Phylogenetic Analysis Reveals the Global Migration of Seasonal Influenza A Viruses. PLoS Pathogens 2007; 3(9):1220-1228
  • Neuzil K, Reed G, Mitchel E, et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148:1094-1102
  • Okamoto S, Kamiya I, Kishida K, Shimakawa T, Fukuy T, Morimoto T. Experience with oseltamivir for infants younger than 1 year old in Japan. Pediatr Infect Dis J 2005; 24:575-576
  • Olsen C. Influenza: Pigs, People and Public Health. Public Health Fact Sheet 2004; 2(6)
  • Organización Mundial de la Salud (OMS). Recomendaciones de la OMS con respecto a las vacunas contra la gripe por A (H1N1). Nota informativa núm.2Julio, 2009. http://www. Who .int/csr/ disease /swine flu /notes /h1n1 _ vaccine _2009 0713/es/ index.h (accesado Julio, 2009)
  • Oxford J, Sefton A, Jackson R, Innes W, Daniels R, Johnson N. World War I may have allowed the emergence of “Spanish” influenza. The Lancet Infectious Diseases 2002; 2:111-114
  • Oxford J. Antivirals for the treatment and prevention of epidemic and pandemic influenza. Influenza Other Respi Viruses 2007; 1(1):27-34
  • Park A, Glass K. Dynamic patterns of avian and human influenza in east and southeast Asia. Lancet Infect Dis 2007; 7:543-548
  • Payungporn S, Crawford P, Kouo T, Chen L, Pompey J, Castleman W, Dubovi E, Katz J, Donis R. Influenza A virus (H3N8) in Dogs with Respiratory Disease, Florida. EID 2008; 14(6)
  • Poland G, Jacobson R, Targonski P. Avian and pandemic influenza: An overview. Vaccine 2007; 25:3057-3061
  • Reece P. Neuraminidase inhibitor resistance in influenza viruses. J Med Virol 2007; 79:1577-1586
  • Roberts N. Treatment of influenza with neuraminidase inhibitors: virological implications. R Soc Lond 2001; 356:1895-1897
  • Russell C, Jones T, Barr I, Cox N, Garten R, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008; 26S:D31-D34
  • Shaman J, Kohn M. Absolute humidity modulates influenza survival, transmission, and seasonality. PNAS 2009; 106(9): 3243-3248
  • Shetty P. Preparation for a pandemic: influenza A H1N1. The Lancet 2009; 9:339-340
  • Sreta D, Kedkovid R, Twamsang S, Kitikoon P, Thanawongnuwech R. Pathogenesis of swine influenza virus (Thai isolates) in weanling pigs: an experimental trial. Virology Journal 2009; 6:34
  • Subbarao K, et al. Characterization of an avian influenza virus isolated from a child with a fatal respiratory illness. Science 1998; 279:393-396
  • Suzuki Y, Ito T, Suzuki T, Holland R, Chambers T, Kiso M, et al. Sialic acid species as a determinant of the host range of influenza A viruses. J Virol 2000; 74:11825-11831
  • Tanaka T, Nakajima K, Murashima A, García-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ 2009; 18(1-2):55-58
  • Tellier R. Review of Aerosol Transmission of Influenza A Virus. Emerging Infectious Diseases 2006; 22(11):1657-1662
  • The Merck Manual. Section Infectious Diseases: Selected Viruses that infect humans. 2005
  • Thompson W, Shay D, Weintraub E, Brammer L, Bridges C, Cox N, Fukuda K. Influenza-Associated Hospitalizations in the United States. JAMA 2004; 292(11):1333-1340
  • van Riel D, Munster V, de Wit E, Rimmelzwaan G, Fouchier R, Osterhaus A, et al. H5N1 virus attachment to lower respiratory tract. Science 2006; 312(5772):399
  • Wai Fu N, Ka Fai T. Pathology of human H5N1 infection: new findings. Lancet 2007; 370:1106-1108
  • Webby R, Rosowk K, Erickson G, Sims Y, Webster R. Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population. Virus Research 2004; 103(1-2):67-73
  • Webster R. Influenza: An Emerging Disease. Emerging Infectious Diseases 1998; 4(3):436-441
  • Webster R. The importance of animal influenza for human disease. Vaccine 2002; 20:S16-S20
  • Wentges-van H, van Eijkeren M, van der Laan J. Oseltamivir and breastfeeding. Int J Infect Dis 2008; 12:451
  • WHO/IVR. State of the art of new vaccines Research & Development. Initiative for Vaccine Research-World Health Organization. Geneva, April 2003
  • Winquist A, Fukuda K, Bridges C, Cox N. Neuraminidase Inhibitors for Treatment of Influenza A and B Infections. MMWR 1999; 48(RR14). Centers for Disease Control and Prevention, Atlanta.
  • Wit E, Fouchier R. Emerging influenza. Journal of Clinical Virology 2008; 41:1-6
  • World Health Organization (WHO). Swine influenza frequently asked questions. http://www. Who .int/csr /disease /swine flu /flaq/e n/print--- (accesado Abril, 2009)
  • World Organization for Animal Health (OIE). What is African Swine fever? In: Chapter 15.1, Terrestrial Animal Health Code 2008
  • World Organization for Animal Health (OIE). What is Classical Swine Fever? In: Chapter 15.1, Terrestrial Animal Health Code 2008
  • Xu C, Dong L, Xin L, Lan Y, Chen Y, Yang L, Shu Y. Human avian influenza A (H5N1) virus infection in China. Sci China Ser C-Life Sci 2009; 52(5):407-411
  • Yamashita M, Tomozawa T, Kakuta M, Tokumitsu A, Nasu H, Kubo S. CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Vírus Activity. Antimicrobial Agents and Chemotherapy 2009; 53(1):186-192


Revista Electronica de PortalesMedicos.com
INICIO - NOVEDADES - ÚLTIMO NÚMERO - ESPECIALIDADES - INFORMACIÓN AUTORES
© PortalesMedicos, S.L.
PortadaAcerca deAviso LegalPolítica de PrivacidadCookiesPublicidadContactar